Heart Failure and Related Risk-factors After Preeclampsia (QoH)
Queen of Hearts Research Program. Identifying the Risk on Heart Failure After Preeclampsia.
Sponsor: Amsterdam UMC, location VUmc
A observational or N/A phase clinical study on Cardiovascular Diseases and Heart Failure, this trial is ongoing. The trial is conducted by Amsterdam UMC, location VUmc and has accumulated 14 data snapshots since 2014. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
14 versions recorded-
Aug 2025 — Present [monthly]
Unknown
Status: Enrolling By Invitation → Unknown
-
Sep 2024 — Aug 2025 [monthly]
Enrolling By Invitation
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation
-
Sep 2022 — Jul 2024 [monthly]
Enrolling By Invitation
Status: Unknown Status → Enrolling By Invitation
-
May 2022 — Sep 2022 [monthly]
Unknown Status
▶ Show 9 earlier versions
-
Dec 2021 — May 2022 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Nov 2018 — Nov 2020 [monthly]
Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Dec 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Amsterdam UMC, location VUmc
- Dutch Heart Foundation
- Leiden University Medical Center
- Maastricht University Medical Center
- UMC Utrecht
- University Medical Center Groningen
For direct contact, visit the study record on ClinicalTrials.gov .